Articles by Jim Miller - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Jim Miller

Preparing for the Last War

CROs that have made big acquisitions could be outmaneuvered by evolving sourcing models.
Oct 2, 2011

CROs that have made big acquisitions could be outmaneuvered by evolving sourcing models.

The EU Debt Crisis and CMOs

The EU debt crisis portends of possible negative repercussions for the dose CMO industry.
Sep 2, 2011

The EU debt crisis portends of possible negative repercussions for the dose CMO industry.

Healthy Outlook for Pharma Services

Respondents to the 2011 PharmSource-Pharmaceutical Technology Outsourcing Survey paint a positive picture, but concerns linger under the surface. This article is part of a special issue on Outsourcing.
Aug 1, 2011

Respondents to the 2011 PharmSource-Pharmaceutical Technology Outsourcing Survey paint a positive picture, but concerns linger under the surface. This article is part of a special issue on Outsourcing.

Supply Chain Pain

Lessons from the earthquake in Japan show the vulnerability of the bio/pharma supply chain.
Jun 2, 2011

Lessons from the earthquake in Japan show the vulnerability of the bio/pharma supply chain.

Supply Chain Pain

Lessons from the earthquake in Japan show the vulnerability of the bio/pharma supply chain.
May 2, 2011

Lessons from the earthquake in Japan show the vulnerability of the bio/pharma supply chain.

A First Hand Look at India's Pharma Services Sector

Indian manufacturers are not a near-term threat to Western CMOs, but may be long term.
Apr 6, 2011

Indian manufacturers are not a near-term threat to Western CMOs, but may be long term.

A First-Hand Look at India's Pharma Services Sector

Indian manufacturers are not a near-term threat to Western CMOs, but may be long term.
Mar 2, 2011

Indian manufacturers are not a near-term threat to Western CMOs, but may be long term.

What to Watch for in 2011

CDMOs and CMOs face weak economic recovery, consolidation, and globalization.
Feb 2, 2011

CDMOs and CMOs face weak economic recovery, consolidation, and globalization.

The Preferred-Provider Model

The designation of preferred partners has become integral to the outsourcing process. Read this and other preferred organization articles in this special issue.
Feb 1, 2011

The designation of preferred partners has become integral to the outsourcing process. Read this and other preferred organization articles in this special issue.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
FindPharma Custom Search
Click here